Resistant hypertension
Clinical trials for Resistant hypertension explained in plain language.
Never miss a new study
Get alerted when new Resistant hypertension trials appear
Sign up with your email to follow new studies for Resistant hypertension, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Neck implant aims to tame stubborn high blood pressure
Disease control CompletedResearchers are studying the long-term safety and effectiveness of the Barostim Neo System in people with uncontrolled high blood pressure who already received the implant. Participants continue their usual blood pressure medications while the device stimulates nerves in the neck…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a new pill tame blood pressure that Won't budge?
Disease control CompletedThis trial tests an experimental pill called SAL0120, taken once a day, in adults whose blood pressure stays high even when they already take two or more blood pressure medicines. About 256 people aged 18 to 75 with uncontrolled or resistant hypertension will receive either a low…
Matched conditions: RESISTANT HYPERTENSION
Phase 3 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug aimed at stubborn high blood pressure passes final trial phase
Disease control CompletedThis Phase 3 trial tested a once-daily pill called baxdrostat in 218 adults with resistant hypertension—high blood pressure that stays high despite taking three or more medications. Participants received either baxdrostat or a placebo for 12 weeks. The main goal was to see if bax…
Matched conditions: RESISTANT HYPERTENSION
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug baxdrostat aims to tame stubborn high blood pressure
Disease control CompletedThis Phase 3 trial tested a daily pill called baxdrostat in about 800 adults whose blood pressure stays high even when taking two or more other medications. Participants received either 1 mg, 2 mg, or a placebo for 12 weeks. The main goal was to see if baxdrostat could safely low…
Matched conditions: RESISTANT HYPERTENSION
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New pill could tame stubborn high blood pressure
Disease control CompletedThis Phase 3 trial tested a new drug called lorundrostat in over 1,000 adults whose high blood pressure remained uncontrolled despite taking 2 to 5 other medications. Participants received either lorundrostat or a placebo daily for 12 weeks. The main goal was to see if the drug l…
Matched conditions: RESISTANT HYPERTENSION
Phase 3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New pill may help when blood pressure meds aren't enough
Disease control CompletedThis study tested a new drug called baxdrostat in 326 adults whose high blood pressure was not controlled even with two or more medications. Participants took either 1 mg, 2 mg of baxdrostat, or a placebo daily for 12 weeks. The main goal was to see if baxdrostat could lower syst…
Matched conditions: RESISTANT HYPERTENSION
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot could tame stubborn high blood pressure
Disease control CompletedThis study tested a new drug called XXB750 in 189 people with resistant hypertension—high blood pressure that doesn't get better with standard treatments. Participants received either a placebo or one of several doses of XXB750 as a shot under the skin, on top of their usual medi…
Matched conditions: RESISTANT HYPERTENSION
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Gout drug allopurinol may boost heart function in african americans with resistant hypertension
Symptom relief CompletedThis study tests whether allopurinol, a common gout medication, can improve heart function in African American veterans with resistant hypertension. Participants take allopurinol for 8 weeks, and researchers measure changes in heart function, exercise ability, and quality of life…
Matched conditions: RESISTANT HYPERTENSION
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Talking to a nurse may ease blood pressure pill side effects
Symptom relief CompletedThis study tested whether one-on-one sessions with a trained nurse could help people with resistant hypertension better handle side effects like sexual problems and bladder control issues caused by their blood pressure medications. The goal was to see if this education helps pati…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Consorci Sanitari Integral • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Skin blood flow test may predict heart danger in tough-to-treat high blood pressure
Knowledge-focused CompletedThis completed study looked at 111 people to see if measuring blood flow in the skin can help assess cardiovascular risk in those with resistant hypertension (high blood pressure that doesn't respond to multiple drugs). Researchers used a laser device to check how well tiny blood…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: National Institute of Cardiology, Laranjeiras, Brazil • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Hidden hormone link in stubborn high blood pressure revealed
Knowledge-focused CompletedThis study looked at over 1,100 adults in the US whose high blood pressure stays high despite taking multiple medications. Researchers checked if these people also have a hormone condition called endogenous hypercortisolism, where the body makes too much cortisol. Participants ga…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC